-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Missfresh, Molecular Partners, TG Therapeutics, and 17EdTech and Encourages Investors to Contact the Fi
-
-
-
-
-
-
-
Emergency Use Authorization Request for Ensovibep Submitted to theĀ US Food and Drug Administration for the Treatment of COVID-19
-
-
-
-
-
-
-
Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Therapeutic Candidates for Oncology
-
-
-
-
-
-
-
Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro
-
-
-
-
-
-
-
Molecular Partners Present Data Demonstrating Successful Inhibition of COVID19 Viral Variants with Ensovibep at the 2021 ISIRV-WHO Conference
-
-
-
14,665 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

